Literature DB >> 10227421

GABA(A) receptors mediate inhibition of T cell responses.

J Tian1, C Chau, T G Hales, D L Kaufman.   

Abstract

We describe the presence of functional GABA(A) receptors on T cells. GABA inhibited anti-CD3 and antigen-specific T cell proliferation in vitro in a dose-dependent manner that was 1) mimicked by the GABA(A) receptor agonist muscimol (but not the GABA(B) receptor agonist baclofen), 2) blocked by GABA(A) receptor antagonists and a GABA(A) receptor Cl- channel blocker (picrotoxin) and 3) enhanced by pentobarbital. These data suggest that GABA(A) receptors mediate this immune inhibition and that these receptors can be modulated in a similar fashion to their neuronal counterparts. Finally, GABA inhibited DTH responses in vivo. Thus, pharmacological modulation of GABA(A) receptors may provide new approaches to modulate T cell responses in inflammation and autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227421     DOI: 10.1016/s0165-5728(98)00264-1

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  69 in total

1.  Distribution and quantitative detection of GABAA receptor in Carassius auratus gibelio.

Authors:  Jiming Ruan; Kun Hu; Haixin Zhang; Yi Wang; Ailing Zhou; Yini Zhao; Xianle Yang
Journal:  Fish Physiol Biochem       Date:  2014-04-01       Impact factor: 2.794

Review 2.  No quiet surrender: molecular guardians in multiple sclerosis brain.

Authors:  Lawrence Steinman
Journal:  J Clin Invest       Date:  2015-04-01       Impact factor: 14.808

Review 3.  Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia?

Authors:  Henry Silver; Yael Chertkow; Orly Weinreb; Lena Danovich; Moussa Youdim
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

Review 4.  Neuroimmune Communication in Health and Disease.

Authors:  Colin Reardon; Kaitlin Murray; Alan E Lomax
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

5.  Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis.

Authors:  Jide Tian; Jing Yong; Hoa Dang; Daniel L Kaufman
Journal:  Autoimmunity       Date:  2011-05-23       Impact factor: 2.815

6.  Etomidate Mitigates Lipopolysaccharide-Induced CD14 and TREM-1 Expression, NF-κB Activation, and Pro-inflammatory Cytokine Production in Rat Macrophages.

Authors:  Ming Liu; Yu Zhang; Jun-Yu Xiong; Yan Wang; Shen Lv
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

Review 7.  Advantages of an antagonist: bicuculline and other GABA antagonists.

Authors:  Graham A R Johnston
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

8.  Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis.

Authors:  Naresha Saligrama; Laure K Case; Roxana del Rio; Rajkumar Noubade; Cory Teuscher
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

9.  Glycine and glycine receptor signalling in non-neuronal cells.

Authors:  Jimmy Van den Eynden; Sheen Saheb Ali; Nikki Horwood; Sofie Carmans; Bert Brône; Niels Hellings; Paul Steels; Robert J Harvey; Jean-Michel Rigo
Journal:  Front Mol Neurosci       Date:  2009-08-20       Impact factor: 5.639

10.  Transgenically induced GAD tolerance curtails the development of early beta-cell autoreactivities but causes the subsequent development of supernormal autoreactivities to other beta-cell antigens.

Authors:  Jide Tian; Hoa Dang; Harald von Boehmer; Elmar Jaeckel; Daniel L Kaufman
Journal:  Diabetes       Date:  2009-09-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.